Related Experiment Video
Updated: Dec 19, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis
Ning Zhou1, Xiaofei Zhu1, Libo Man1
1Department of Urology, Beijing Jishuitan Hospital, Beijing 100035, People's Republic of China.
Purpose:
Long non-coding RNAs have been found to be involved in bladder cancer development. This article studied LINC00963 effects on bladder cancer progression to provide a novel treatment target.
Patients And Methods:
Totally 56 bladder cancer patients participated in this research. Bladder cancer cells were transfected. Cell counting kit 8 assay and clone formation experiment were used for cell viability and colony formation detection. Cell migration and invasion were determined by Transwell experiment. LINC00963 distribution was explored by cytoplasmic and nuclear extract isolation and quantitative real-time polymerase chain reaction. Luciferase reporter experiment and RNA pulldown experiment were performed to detect the relationship between these two genes. The cancer genome atlas analysis was used for the detection of metastasis-associated protein 1 (MTA1) expression in bladder cancer.
Results:
LINC00963 was seriously up-regulated in bladder cancer patients. High LINC00963 expression indicated high histological grade and low survival. LINC00963 was obviously up-regulated in bladder cancer cells. Knockdown of LINC00963 significantly reduced bladder cancer cells viability, colony formation, migration and invasion. Luciferase reporter experiment and RNA pulldown experiment revealed that LINC00963 promoted MTA1 expression via directly inhibiting miR-766-3p. MTA1 was up-regulated in bladder cancer patients. MTA1 up-regulation reversed the inhibitory effect of LINC00963 knockdown on bladder cancer cell viability, migration and invasion.
Conclusion:
LINC00963 functions as an oncogene in bladder cancer by regulating the miR-766-3p/MTA1 axis.
Insights
Long non-coding RNA LINC00963 acts as an oncogene in bladder cancer. It promotes tumor progression by regulating the miR-766-3p/MTA1 pathway, suggesting a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play a role in cancer development.
- LINC00963 is implicated in bladder cancer progression.
Purpose of the Study:
- Investigate the role of LINC00963 in bladder cancer.
- Identify LINC00963 as a potential therapeutic target.
Main Methods:
- Analysis of 56 bladder cancer patients.
- Cell viability, colony formation, migration, and invasion assays.
- Quantitative real-time PCR, luciferase reporter, and RNA pulldown assays.
- The Cancer Genome Atlas (TCGA) analysis for MTA1 expression.
Main Results:
- LINC00963 is upregulated in bladder cancer, correlating with poor survival.
- LINC00963 knockdown inhibits bladder cancer cell proliferation, migration, and invasion.
- LINC00963 promotes metastasis-associated protein 1 (MTA1) expression by inhibiting miR-766-3p.
- MTA1 upregulation reverses the inhibitory effects of LINC00963 knockdown.
Conclusions:
- LINC00963 functions as an oncogene in bladder cancer.
- The LINC00963/miR-766-3p/MTA1 axis drives bladder cancer progression.
- LINC00963 represents a novel therapeutic target for bladder cancer.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs

